Valneva is a specialty vaccine company focused on prevention against diseases with major unmet needs. The Company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19 and chikungunya. Valneva’s portfolio also includes two commercial vaccines for travelers.
Valneva at a glance
Commercial vaccines for travelers
€m
Product sales revenues in 2019
Unique vaccine development programs
Specialized
Travel vaccines
Vector-transmitted diseases
Focused
On prevention against diseases with major medical needs
> 500
employees in six countries